S Yusuf Selected Research

Irbesartan

6/2006	Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
6/2006	Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Yusuf Research Topics

Disease

24	Heart Failure 04/2013 - 01/2000
22	Myocardial Infarction 01/2012 - 01/2000
17	Stroke (Strokes) 05/2015 - 01/2000
14	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 07/2000
9	Hypertension (High Blood Pressure) 07/2016 - 07/2000
9	Glucose Intolerance 09/2014 - 07/2000
8	Acute Coronary Syndrome 05/2004 - 06/2000
7	Hemorrhage 01/2018 - 06/2000
7	Unstable Angina 05/2004 - 01/2000
6	Type 2 Diabetes Mellitus (MODY) 09/2014 - 09/2006
5	Vascular Diseases (Vascular Disease) 01/2023 - 01/2000
5	Obesity 08/2015 - 10/2001
5	Atrial Fibrillation 05/2012 - 09/2001
4	Coronary Disease (Coronary Heart Disease) 02/2010 - 01/2000
4	Atherosclerosis 02/2010 - 01/2000
4	Left Ventricular Dysfunction 07/2001 - 01/2000
4	Infarction (Infarctions) 01/2001 - 05/2000
2	Abdominal Obesity 08/2015 - 10/2001
2	Anemia 05/2015 - 01/2014
2	Infections 01/2014 - 03/2001
2	Overweight 02/2013 - 02/2010
2	Neoplasms (Cancer) 01/2012 - 01/2000
2	Renal Insufficiency (Renal Failure) 05/2008 - 04/2001
2	Hypotension (Low Blood Pressure) 06/2000 - 04/2000
1	Leiomyosarcoma 01/2020
1	Albuminuria 07/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2015
1	Parasitemia 01/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2012
1	Body Weight (Weight, Body) 11/2011
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2010
1	Kidney Diseases (Kidney Disease) 05/2008
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2007
1	Insulin Resistance 09/2006

Drug/Important Bio-Agent (IBA)

14	Ramipril (Altace)FDA LinkGeneric 11/2010 - 01/2000
13	Glucose (Dextrose)FDA LinkGeneric 09/2014 - 08/2000
13	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2008 - 01/2000
11	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2010 - 06/2000
8	Clopidogrel (Plavix)FDA Link 02/2010 - 12/2000
6	Rosiglitazone (Avandia)FDA Link 09/2014 - 09/2004
5	LDL CholesterolIBA 02/2010 - 07/2000
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2007 - 01/2000
4	Dabigatran FDA Link 01/2018 - 11/2011
4	CreatinineIBA 07/2015 - 04/2001
4	candesartanIBA 01/2007 - 01/2000
4	Heparin (Liquaemin)FDA LinkGeneric 01/2002 - 06/2000
4	Vitamin E FDA LinkGeneric 07/2001 - 01/2000
3	SodiumIBA 01/2019 - 04/2013
3	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 12/2000
3	AnticoagulantsIBA 05/2015 - 06/2006
3	CholesterolIBA 01/2010 - 07/2000
3	HDL CholesterolIBA 01/2008 - 07/2000
3	HirudinsIBA 01/2002 - 09/2000
3	Fibrinogen (Factor I)FDA Link 10/2001 - 07/2000
3	Plasminogen Activators (Plasminogen Activator)IBA 10/2001 - 07/2000
2	Vitamin D FDA LinkGeneric 01/2023 - 01/2012
2	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2012 - 09/2006
2	LipidsIBA 02/2010 - 01/2005
2	Insulin (Novolin)FDA Link 02/2010 - 08/2000
2	Telmisartan (Micardis)FDA Link 09/2008 - 03/2007
2	Irbesartan FDA LinkGeneric 06/2006 - 06/2006
2	PlacebosIBA 07/2001 - 02/2001
2	Radioisotopes (Radionuclides)IBA 01/2001 - 08/2000
2	HomocysteineIBA 11/2000 - 07/2000
2	Triglycerides (Triacylglycerol)IBA 11/2000 - 07/2000
2	Lipoprotein(a)IBA 11/2000 - 07/2000
2	candesartan cilexetil (Amias)FDA Link 04/2000 - 01/2000
1	phenithionate (7720)IBA 08/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2014
1	ThiazolidinedionesIBA 09/2014
1	AdiponectinIBA 09/2014
1	AdipokinesIBA 09/2014
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2014
1	Lactose FDA LinkGeneric 01/2014
1	SaltsIBA 04/2013
1	CarbohydratesIBA 02/2013
1	Pioglitazone (Actos)FDA Link 01/2012
1	Cholecalciferol (Vitamin D3)FDA Link 01/2012
1	Hemoglobins (Hemoglobin)IBA 11/2011
1	Thrombin FDA Link 11/2011
1	Biomarkers (Surrogate Marker)IBA 02/2010
1	ApolipoproteinsIBA 02/2010
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2010
1	Fondaparinux (Arixtra)FDA Link 02/2010
1	Enoxaparin (Lovenox)FDA LinkGeneric 02/2010
1	Atenolol (Tenormin)FDA LinkGeneric 04/2009
1	Simvastatin (Zocor)FDA LinkGeneric 04/2009
1	ThiazidesIBA 04/2009
1	Angiotensin Receptor AntagonistsIBA 09/2008
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2007
1	2,6-dinitrotoluene (DNT)IBA 04/2006

Therapy/Procedure

10	Therapeutics 11/2011 - 05/2000
2	Contraindications 06/2006 - 09/2000
2	Thrombolytic Therapy 04/2006 - 01/2001
2	Percutaneous Coronary Intervention 01/2002 - 07/2001
1	Neoadjuvant Therapy 01/2020
1	Secondary Prevention 01/2019
1	Drug Therapy (Chemotherapy) 02/2010
1	Transjugular Intrahepatic Portasystemic Shunt 04/2009